ITCA 650 Significantly Reduces the Need to Advance Antidiabetes Therapy Compared with Sitagliptin

Rosenstock, J; Prabhakar, P; Kjems, L; Huang, H; Baron, M

DIABETES, 2017; 66 ( ): A295